Description
Jeena Sikho Lifecare Limited's equity shares will migrate from SME EMERGE platform to NSE Capital Market Segment (Main Board) effective August 11, 2025.
Summary
Jeena Sikho Lifecare Limited (JSLL) will migrate from NSE’s SME EMERGE platform to the Capital Market Segment (Main Board) effective August 11, 2025. The company was originally listed on SME EMERGE platform on April 18, 2022.
Key Points
- Trading symbol: JSLL
- ISIN: INE0J5801029
- Face value: Rs. 2/- per share
- Total securities: 124,300,730 equity shares
- Market lot size: 1 share
- Series: EQ (Equity)
- Migration effective from August 11, 2025
Regulatory Changes
The equity shares will be admitted to dealings on the National Stock Exchange Capital Market Segment (Main Board) instead of the SME EMERGE platform.
Compliance Requirements
No specific compliance requirements mentioned for market participants. The migration appears to be administrative in nature.
Important Dates
- August 11, 2025: Effective date for migration to Main Board
- April 18, 2022: Original listing date on SME EMERGE platform
Impact Assessment
The migration to Main Board typically provides:
- Enhanced liquidity and visibility
- Access to broader investor base
- Higher regulatory standards and compliance requirements
- Potential for inclusion in broader market indices
Company Details
Registered Office: SCO 11 First Floor, Kalgidhar Enclave, Mohali, Zirakpur, Punjab – 140604
Company Secretary: Ms. Smita Chaturvedi (cs@jeenasikho.com)
Registrar: Skyline Financial Services Private Limited, New Delhi
Financial Year: April 01 - March 31
Impact Justification
Company migration from SME to main board affects trading platform and investor access